WealthShield Partners’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
RCM
WealthShield Partners's NVAX Position: Q3 2021 in Review
WealthShield Partners sold out of Novavax (NVAX) in Q3 2021, closing a stake of 500 shares — an estimated $106K sold.
WealthShield Partners first reported a position in NVAX in Q1 2021 and held it in 2 quarters. The position peaked at $106K in Q2 2021. 442 funds tracked by Wall St. Rank hold NVAX as of Q3 2021.
- WealthShield Partners reported no remaining Novavax position as of Q3 2021 after selling out during the quarter.
- WealthShield Partners sold 500 Novavax shares in Q3 2021, an estimated $106K.
- WealthShield Partners first reported a position in Novavax in Q1 2021 and held it in 2 quarters.
- WealthShield Partners's Novavax position peaked at $106K in Q2 2021.
- 442 funds tracked by Wall St. Rank held Novavax as of Q3 2021.
Based on WealthShield Partners's 13F filing for Q3 2021, filed 12 Nov 2021.